How to conduct a gap analysis using GLI quality essentials for TB lab accreditation
Accreditation readiness begins with a clear understanding of how a tuberculosis laboratory currently operates. A gap analysis compares existing practices, records, facilities, and staff competencies with defined quality requirements. It shows where the laboratory is compliant, where evidence is incomplete, and where corrective action is needed before an external assessment.
The GLI Quality Tool provides a practical framework for this work. Its four-phase roadmap is organized around twelve Quality Systems Essentials (QSEs), allowing laboratories to progress from basic organization and planning to implementation, monitoring, and continual improvement. The approach can be adapted to different testing platforms, staffing models, and resource settings.
A useful gap analysis is more than a checklist exercise. It should produce reliable evidence, involve the people who perform daily laboratory work, and connect each finding to a realistic improvement plan. When used consistently, it becomes a foundation for quality management system development and TB laboratory accreditation.
Define the scope and prepare the team
Start by defining which parts of the laboratory will be reviewed. The scope may include sputum reception, specimen processing, smear microscopy, molecular testing, culture, drug susceptibility testing, results reporting, or support functions such as procurement and equipment maintenance. Include referral, transport, and biosafety processes when they affect testing quality.
Identify a small assessment team with complementary knowledge. A laboratory manager can coordinate the review, while section supervisors, quality officers, biosafety personnel, equipment users, and administrative staff contribute operational insight. If possible, include someone who understands the applicable accreditation standard, such as ISO 15189, and national TB laboratory policies.
Before beginning, read the user instructions for the GLI Quality Tool. Clarify how the phases and checklists are intended to be used, gather the relevant downloadable materials, and agree on terminology. The team should also establish a schedule, assign responsibilities, and decide how findings will be documented and prioritized.
Map the laboratory against the twelve essentials
The twelve QSEs provide a comprehensive map of the laboratory quality system. They cover organization, personnel, equipment, purchasing and inventory, process management, information management, documents and records, customer focus, assessment, facilities and safety, occurrence management, and continual improvement.
Review each essential through three types of evidence: what is written, what is done, and what is recorded. For example, a laboratory may have a procedure for equipment calibration, but the gap analysis must verify whether staff follow it and whether current calibration certificates are available. A policy without implementation evidence should not be treated as full compliance.
Use interviews, direct observation, document review, and record sampling together. Interview staff about routine practice, observe critical steps such as specimen labeling and result verification, and sample quality control records, maintenance logs, temperature charts, training files, and corrective action reports. Triangulating evidence reduces the risk of accepting an outdated document or overlooking informal workarounds.
Apply a consistent rating method
A simple rating system makes findings easier to interpret. Laboratories can classify each requirement as fully implemented, partially implemented, not implemented, or not applicable. The assessment should also record whether objective evidence was found and whether the finding creates a direct risk to patients, staff, results, or regulatory compliance.
| Rating | Meaning | Typical evidence | Immediate response |
|---|---|---|---|
| Fully implemented | The requirement is defined, followed, and supported by current records | Approved procedure, observed practice, complete monitoring records | Maintain and periodically verify |
| Partially implemented | Some elements exist, but application or evidence is inconsistent | Procedure exists, but training or records are incomplete | Assign corrective action and deadline |
| Not implemented | The requirement is absent or not functioning | No procedure, responsible person, or supporting record | Treat as a significant priority |
| Not applicable | The requirement does not apply to the laboratory’s scope | No culture service where culture is outside the approved menu | Document the rationale |
| Immediate risk | A condition may compromise safety or result validity | Unsafe specimen handling or uncontrolled critical equipment | Contain the risk before longer-term action |
Avoid scoring based on impressions alone. A high percentage of completed checklist items does not necessarily indicate accreditation readiness if unresolved findings affect biosafety, test validity, result authorization, or traceability. The assessment team should write concise evidence-based findings, identify the affected QSE, and explain the consequence of the gap.
Examine high-risk technical and safety processes
The most urgent gaps often occur in processes that directly influence specimen integrity, staff safety, and reported results. Follow a specimen through the complete pathway: collection or receipt, accessioning, labeling, storage, preparation, testing, result review, reporting, and disposal. Look for points where identification, contamination control, turnaround time, or confidentiality could fail.
Biosafety deserves special attention in TB laboratories because aerosol-generating activities may occur during sputum processing. Review risk assessments, personal protective equipment, respiratory protection, biological safety cabinet certification, ventilation, spill response, waste handling, exposure reporting, and staff health procedures. The resource on managing biosafety risks can support a more detailed review of sputum-processing hazards.
Equipment and reagent management should be assessed with the same rigor. Confirm that instruments are suitable for their intended use, installed correctly, maintained according to schedule, and supported by service records. Check reagent receipt, storage conditions, lot verification, expiry control, stock monitoring, and contingency arrangements for shortages or equipment downtime.
Quality control and external quality assessment results can reveal hidden weaknesses. Examine invalid rates, contamination rates, repeat testing, proficiency testing performance, rejected specimens, delayed reports, and discordant results. These indicators help connect a checklist finding with actual laboratory performance.
Convert findings into a prioritized action plan
After collecting evidence, group related gaps rather than creating repetitive actions. For instance, missing competency assessments, inconsistent refresher training, and incomplete personnel files may belong to one broader personnel-management problem. Grouping findings helps managers address root causes instead of treating every symptom separately.
Prioritize according to risk, accreditation significance, feasibility, and dependency. A biosafety hazard or failure to control critical test conditions usually takes precedence over a minor formatting issue in a document. Some actions must occur before others: the laboratory may need to define responsibilities before it can implement a document-control system, or repair ventilation before safely expanding testing.
Each action should have an owner, deadline, required resources, success measure, and verification method. A practical action statement is specific: “The quality officer will introduce monthly review of temperature excursions, document root-cause analysis, and present trends at the quality meeting for three consecutive months.” This is more useful than “Improve equipment monitoring.”
- Resolve immediate risks through containment, supervision, or temporary suspension of an unsafe activity.
- Assign one accountable person to every corrective action, even when several departments contribute.
- Separate quick improvements from actions requiring funding, procurement, construction, or external support.
- Verify completion with objective evidence, such as approved procedures, training records, audit results, or observed practice.
- Record unresolved risks and review them at scheduled management meetings.
Use the four phases as a development cycle
The GLI roadmap helps laboratories avoid trying to implement every quality requirement at once. In the initial phase, establish leadership commitment, define responsibilities, understand the current situation, and identify urgent risks. The gap analysis provides the baseline for selecting realistic priorities.
The next phase focuses on building the quality system: developing controlled documents, organizing records, training personnel, managing equipment and supplies, and standardizing technical processes. At this stage, the laboratory should ensure that procedures are approved, accessible at points of use, reviewed periodically, and protected from unintended changes.
The implementation and monitoring phases require evidence that the system works in routine conditions. Internal audits, management reviews, quality indicators, occurrence investigations, customer feedback, and corrective actions should become regular activities. Progress should be measured against the original baseline, with repeated assessments used to confirm whether gaps have actually closed.
A phase-based approach also helps laboratory leaders communicate resource needs. Instead of requesting general support for “quality improvement,” they can link funding or technical assistance to specific requirements, such as backup power, staff competency assessment, calibration, information systems, or biosafety improvements.
Sustain readiness through review and evidence
Accreditation preparation should not end when the initial gap analysis report is approved. Establish a review calendar based on risk, with more frequent checks for critical activities and less frequent review for stable, low-risk processes. Repeat targeted assessments after corrective actions and conduct a broader QSE review when services, instruments, premises, or staffing change.
Maintain an evidence trail that an assessor can follow. Documents should have version control, approval dates, and defined retention periods. Records should be legible, attributable, protected, and retrievable. Corrective action files should show the original finding, root-cause analysis, action taken, effectiveness check, and closure decision.
Staff engagement is essential for sustainability. Share results in practical language, recognize improvements, and use incidents as opportunities to strengthen systems rather than assign blame. Gather feedback from laboratory users and partners about reporting, turnaround time, specimen requirements, and communication. The GLI Quality Tool’s feedback form provides a channel for sharing experience with the resource and supporting its continued relevance.
A well-run gap analysis gives the laboratory a defensible picture of its quality maturity. It identifies the controls that protect patients and personnel, clarifies what evidence is missing, and turns accreditation preparation into a managed improvement program. Begin with the current scope, assess every applicable QSE, prioritize risk, and revisit the findings until daily practice matches the documented system.